NASDAQ:ASMB
Assembly Biosciences Stock Insider Trading
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 3.563.
In total, the insiders bought 3 657 632 and sold 1 089 887 ASMB shares in the last 100 trades.
| Date | Action | Amount | Person | Type |
| Aug 08, 2022 | Sell | 12 314 | Mchutchison John G | Common Stock |
| Aug 01, 2022 | Buy | 200 000 | Delaney William E Iv | Stock Option (right to buy) |
| Aug 01, 2022 | Buy | 250 000 | Okazaki Jason A | Stock Option (right to buy) |
| Jul 25, 2022 | Sell | 2 020 | Samar Michael P. | Common Stock |
| May 31, 2022 | Sell | 4 164 | Delaney William E Iv | Common Stock |
| May 25, 2022 | Buy | 20 000 | Consylman Gina | Stock Option (right to buy) |
| May 25, 2022 | Buy | 20 000 | Houghton Michael | Stock Option (right to buy) |
| May 25, 2022 | Buy | 20 000 | Mahony Susan | Stock Option (right to buy) |
| May 25, 2022 | Buy | 20 000 | Johnson-pratt Lisa | Stock Option (right to buy) |
| May 25, 2022 | Buy | 20 000 | Ringo William R | Stock Option (right to buy) |
| May 25, 2022 | Buy | 20 000 | Dimarchi Richard D | Stock Option (right to buy) |
| May 25, 2022 | Buy | 20 000 | Altig Anthony E | Stock Option (right to buy) |
| Mar 30, 2022 | Sell | 22 500 | Stamm Luisa M | Performance-based Restricted Stock Units |
| Mar 30, 2022 | Sell | 90 000 | Stamm Luisa M | Stock Option (right to buy) |
| Mar 30, 2022 | Sell | 1 038 | Stamm Luisa M | Common Stock |
| Mar 30, 2022 | Sell | 26 250 | Samar Michael P. | Performance-based Restricted Stock Units |
| Mar 30, 2022 | Sell | 105 000 | Samar Michael P. | Stock Option (right to buy) |
| Mar 30, 2022 | Sell | 2 285 | Samar Michael P. | Common Stock |
| Mar 30, 2022 | Sell | 31 250 | Okazaki Jason A | Performance-based Restricted Stock Units |
| Mar 30, 2022 | Sell | 125 000 | Okazaki Jason A | Stock Option (right to buy) |
| Mar 30, 2022 | Sell | 1 269 | Okazaki Jason A | Common Stock |
| Mar 30, 2022 | Sell | 25 000 | Delaney William E Iv | Performance-based Restricted Stock Units |
| Mar 30, 2022 | Sell | 100 000 | Delaney William E Iv | Stock Option (right to buy) |
| Mar 30, 2022 | Sell | 1 038 | Delaney William E Iv | Common Stock |
| Mar 30, 2022 | Sell | 83 750 | Mchutchison John G | Performance-based Restricted Stock Units |
| Mar 30, 2022 | Sell | 335 000 | Mchutchison John G | Stock Option (right to buy) |
| Mar 30, 2022 | Sell | 4 614 | Mchutchison John G | Common Stock |
| Mar 29, 2022 | Buy | 22 500 | Stamm Luisa M | Common Stock |
| Mar 29, 2022 | Buy | 26 250 | Samar Michael P. | Common Stock |
| Mar 29, 2022 | Buy | 31 250 | Okazaki Jason A | Common Stock |
| Mar 29, 2022 | Buy | 25 000 | Delaney William E Iv | Common Stock |
| Mar 29, 2022 | Buy | 83 750 | Mchutchison John G | Common Stock |
| Mar 28, 2022 | Sell | 4 617 | Okazaki Jason A | Common Stock |
| Aug 09, 2021 | Sell | 12 156 | Mchutchison John G | Common Stock |
| Jul 22, 2021 | Buy | 10 938 | Samar Michael P. | Common Stock |
| Jul 19, 2021 | Buy | 30 000 | Houghton Michael | Stock Option (right to buy) |
| May 27, 2021 | Sell | 4 129 | Delaney William E Iv | Common Stock |
| May 20, 2021 | Buy | 30 000 | Johnson-pratt Lisa | Stock Option (right to buy) |
| May 20, 2021 | Buy | 15 000 | Ringo William R | Stock Option (right to buy) |
| May 20, 2021 | Buy | 15 000 | Dimarchi Richard D | Stock Option (right to buy) |
| May 20, 2021 | Buy | 15 000 | Consylman Gina | Stock Option (right to buy) |
| May 20, 2021 | Buy | 15 000 | Altig Anthony E | Stock Option (right to buy) |
| May 20, 2021 | Buy | 15 000 | Holubiak Myron Z | Stock Option (right to buy) |
| May 20, 2021 | Buy | 15 000 | Mahony Susan | Stock Option (right to buy) |
| Mar 29, 2021 | Buy | 11 250 | Delaney William E Iv | Common Stock |
| Mar 29, 2021 | Buy | 67 500 | Delaney William E Iv | Stock Option (right to buy) |
| Mar 29, 2021 | Buy | 11 250 | Russo Thomas Joseph | Common Stock |
| Mar 29, 2021 | Buy | 67 500 | Russo Thomas Joseph | Stock Option (right to buy) |
| Mar 29, 2021 | Buy | 82 500 | Okazaki Jason A | Stock Option (right to buy) |
| Mar 29, 2021 | Buy | 13 750 | Okazaki Jason A | Common Stock |
| Mar 29, 2021 | Buy | 305 000 | Mchutchison John G | Stock Option (right to buy) |
| Mar 29, 2021 | Buy | 11 250 | Stamm Luisa M | Common Stock |
| Mar 29, 2021 | Buy | 67 500 | Stamm Luisa M | Stock Option (right to buy) |
| Dec 14, 2020 | Sell | 1 297 | Papkoff Jacqueline Sybil | Common Stock |
| Nov 09, 2020 | Sell | 4 397 | Stamm Luisa M | Common Stock |
| Oct 19, 2020 | Buy | 20 000 | Consylman Gina | Stock Option (right to buy) |
| Aug 07, 2020 | Sell | 11 395 | Mchutchison John G | Common Stock |
| Aug 07, 2020 | Sell | 756 | Mchutchison John G | Common Stock |
| Jun 11, 2020 | Buy | 10 000 | Kim Helen Susan | Stock Option (right to buy) |
| Jun 11, 2020 | Buy | 10 000 | Lewis Alan | Stock Option (right to buy) |
| Jun 11, 2020 | Buy | 10 000 | Mahony Susan | Stock Option (right to buy) |
| Jun 11, 2020 | Buy | 10 000 | Altig Anthony E | Stock Option (right to buy) |
| Jun 11, 2020 | Buy | 10 000 | Dimarchi Richard D | Stock Option (right to buy) |
| Jun 11, 2020 | Buy | 10 000 | Holubiak Myron Z | Stock Option (right to buy) |
| Jun 11, 2020 | Buy | 10 000 | Ringo William R | Stock Option (right to buy) |
| May 27, 2020 | Buy | 45 000 | Delaney William E Iv | Common Stock |
| May 27, 2020 | Buy | 100 000 | Delaney William E Iv | Stock Option (right to buy) |
| Mar 31, 2020 | Sell | 7 812 | Colonno Richard James | Common Stock |
| Mar 30, 2020 | Sell | 1 254 | Papkoff Jacqueline Sybil | Common Stock |
| Mar 27, 2020 | Buy | 43 383 | Russo Thomas Joseph | Common Stock |
| Mar 27, 2020 | Buy | 17 000 | Papkoff Jacqueline Sybil | Common Stock |
| Mar 27, 2020 | Buy | 34 000 | Papkoff Jacqueline Sybil | Common Stock (right to buy) |
| Mar 27, 2020 | Buy | 50 000 | Mchutchison John G | Common Stock |
| Mar 27, 2020 | Buy | 100 000 | Mchutchison John G | Stock Option (right to buy) |
| Mar 27, 2020 | Buy | 17 000 | Colonno Richard James | Common Stock |
| Mar 27, 2020 | Buy | 34 000 | Colonno Richard James | Stock Option (right to buy) |
| Mar 26, 2020 | Buy | 50 000 | Okazaki Jason A | Common Stock |
| Mar 26, 2020 | Buy | 250 000 | Okazaki Jason A | Stock Option (right to buy) |
| Feb 28, 2020 | Sell | 2 000 | Ringo William R | Common Stock |
| Jan 02, 2020 | Buy | 125 000 | Small Derek A | Common Stock |
| Dec 13, 2019 | Sell | 1 460 | Papkoff Jacqueline Sybil | Common Stock |
| Dec 12, 2019 | Buy | 33 061 | Colonno Richard James | Common Stock |
| Dec 12, 2019 | Sell | 33 061 | Colonno Richard James | Common Stock |
| Dec 12, 2019 | Sell | 33 061 | Colonno Richard James | Stock Option (right to buy) |
| Nov 06, 2019 | Buy | 12 000 | Stamm Luisa M | Common Stock |
| Nov 06, 2019 | Buy | 165 000 | Stamm Luisa M | Stock Option (right to buy) |
| Oct 28, 2019 | Buy | 185 000 | Russo Thomas Joseph | Stock Option (right to buy) |
| Oct 01, 2019 | Buy | 2 500 | Samar Michael P. | Common Stock |
| Oct 01, 2019 | Buy | 27 500 | Papkoff Jacqueline Sybil | Stock Options (right to buy) |
| Oct 01, 2019 | Buy | 5 000 | Samar Michael P. | Stock Option (right to buy) |
| Sep 28, 2019 | Buy | 25 000 | Mchutchison John G | Performance-based Restricted Stock Units |
| Aug 06, 2019 | Buy | 100 000 | Mchutchison John G | Common Stock |
| Aug 06, 2019 | Buy | 500 000 | Mchutchison John G | Stock Option (right to buy) |
| May 17, 2019 | Buy | 10 000 | Auerbach Mark | Stock Option (right to buy) |
| May 17, 2019 | Buy | 10 000 | Mahony Susan | Stock Option (right to buy) |
| May 17, 2019 | Buy | 10 000 | Ringo William R | Stock Option (right to buy) |
| May 17, 2019 | Buy | 10 000 | Altig Anthony E | Stock Option (right to buy) |
| May 17, 2019 | Buy | 10 000 | Lewis Alan | Stock Option (right to buy) |
| May 17, 2019 | Buy | 10 000 | Kim Helen Susan | Stock Option (right to buy) |
| May 17, 2019 | Buy | 10 000 | Holubiak Myron Z | Stock Option (right to buy) |
About Assembly Biosciences
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
